20.6
C
Manchester
Trending now
US stocks hang near their record heights
Ebola outbreak now DR Congo’s deadliest ever
What will TV look like in three…
Why Box-Checking Fails Clinical Research Teams: Justin…
RollingButterflies Expands Professional Video Production and Event…
CJ eyes $8.47 bil. in annual sales…
Solar Heroes Brings Premium Solar Control Window…
The queen who made tradition modern
Ex-comedian Pyo In-bong becomes homeless-serving pastor near…
Sky-Blue Elevates Inflight Service with Design-Led Cutlery…
Home
News
Business
National
Press Release
Finanace
Search for:
Search
Primary Menu
Search for:
Search
Home
Business
FDA vaccine head will step down in April after string of controversial decisions
Business
FDA vaccine head will step down in April after string of controversial decisions
by
Douglas L. Grider
Vinay Prasad is leaving his post as director of the Center for Biologics Evaluation and Research.
previous post
FDA reversals leave investors worrying about the fates of other experimental drugs
next post
[TEST DRIVE] Renault Korea’s Filante set to take on Santa Fe, Sorento
Douglas L. Grider
Related posts
Klarna seeks U.S. bank charter in latest push beyond buy now, pay later
Douglas L. Grider
July 6, 2026
2026 is the year of obesity pills. Here’s how they could reshape the GLP-1 market
Douglas L. Grider
January 10, 2026
Eli Lilly’s top dealmaker says don’t be surprised to see more M&A that pushes Lilly into new areas
Douglas L. Grider
June 3, 2026
